Small Molecule APIs CDMO Services

The development and manufacturing of small molecule active pharmaceutical ingredients (APIs) are crucial steps towards getting effective, high-quality therapies to market. And its successful development and production depends on speed, efficiency, and quality. At our company, our small molecule APIs CDMO service aims to bridge the gap between drug discovery and market-ready products. We can offer essential services throughout the entire project lifecycle, from early process optimization and scale-up to commercial production, to ensure your project successfully reaches the market quickly and efficiently by leveraging state-of-the-art technology and rigorous adherence to industry standards.

We operate a variety of large-scale reactors and production lines, including high-volume batch reactors and continuous flow systems. Our commercial facilities are designed to produce consistently high-quality APIs at scale, adhering to stringent GMP standards that can facilitate a range of reactions, including high-pressure dehydrogenation and cryogenic reactions. Additionally, our flexible production systems allow us to handle a diverse portfolio of small molecule APIs, meeting the unique demands of each project.